MSD (Merck & Co) has won US Food and Drug Administration (FDA) approval for its cholesterol-lowering pill, marking a significant milestone in the drugmaker’s push to reduce revenue reliance on ...

Blood-based biomarkers could play a key role in detecting and treating Alzheimer’s early at the first point of contact, experts say.

The FDA has issued traditional approval to Novartis for Fabhalta to slow the decline of kidney function in adults with primary IgAN who are at risk of disease progression.

Bayer's Kerendia will become available to English patients with chronic heart failure with preserved or mildly reduced ejection fraction.

Harbour BioMed and Kelun-Biotech have received approval from China’s NMPA for their IND application for the HBM7575/SKB575 bispecific antibody intended to treat asthma.

The UK’s Joint Committee on Vaccination and Immunisation (JCVI) has recommended a routine programme with the 4CMenB vaccine for adolescents.

Novo Nordisk is continuing to maintain its advantage in the obesity pill race after winning European approval for oral Wegovy (semaglutide). The European Commission (EC) granted m ...

There are a range of cost-containment measures across the bill that will create a significant healthcare system shakeup.

Cellares and Sonoma Biotherapeutics have partnered to automate the manufacturing of the latter’s SBT-77-7101 programme using the Cellares Cell Shuttle platform.

Telix Pharmaceuticals has opened a radiopharmaceutical facility in Melbourne, Australia, to expedite the delivery of new cancer treatments.

AdvanCell will use the mega-round earnings to progress ADVC001 and build radiopharmaceutical manufacturing infrastructure.

Innovent Biologics has granted Spero Therapeutics an exclusive licence deal to develop and commercialise IBI355 outside Greater China.